Cardiovascular Systems Profit Margin

Cardiovascular Systems (CSII) currently reports a profit margin of -15.79% as of December 2022. That compares with -11.47% in the prior-year period — down 37.7% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Cardiovascular Systems's profit margin history and peer comparisons.

Cardiovascular Systems's profit margin decreased from -11.47% to -15.79% — a 37.7% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cardiovascular Systems's profit margin of -15.79% is lower than the Healthcare sector average of 13.89%. That is roughly 213.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Cardiovascular Systems's current -15.79% should be judged against Healthcare norms (sector average: 13.89%) and against CSII's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -15.79%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Cardiovascular Systems, and consider following CSII for alerts when major investors trade the stock.